Mochida And Ayumi Launch Unique Humira Biosimilar Formulation In Japan

Launch And NHI Listing Follows Approval In March This Year

launch
The biosimilar was first approved in March • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin